Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, New Nordic Healthbrands AB's Enterprise Value is €9.68 Mil.
New Nordic Healthbrands AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was €-0.06 Mil. Therefore, New Nordic Healthbrands AB's EV-to-FCF for today is -151.31.
The historical rank and industry rank for New Nordic Healthbrands AB's EV-to-FCF or its related term are showing as below:
FRA:N9X'
s EV-to-FCF Range Over the Past 10 Years
Min: -279.74 Med: 15.23 Max: 557.78
Current: -201.15
During the past 13 years, the highest EV-to-FCF of New Nordic Healthbrands AB was 557.78. The lowest was -279.74. And the median was 15.23.
FRA:N9X's EV-to-FCF is ranked worse than 100% of 1190
companies
in the Consumer Packaged Goods industry
Industry Median: 15.92
vs FRA:N9X: -201.15
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
New Nordic Healthbrands AB (FRA:N9X) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
New Nordic Healthbrands AB's PE Ratio (TTM) for today is calculated as:
New Nordic Healthbrands AB's share price for today is €1.05.
New Nordic Healthbrands AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.038.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
New Nordic Healthbrands AB EV-to-FCF Related Terms
New Nordic Healthbrands AB EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, New Nordic Healthbrands AB's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
New Nordic Healthbrands AB EV-to-FCF vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, New Nordic Healthbrands AB's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where New Nordic Healthbrands AB's EV-to-FCF falls into.
New Nordic Healthbrands AB's current Enterprise Value is €9.68 Mil.
New Nordic Healthbrands AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.06 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
New Nordic Healthbrands AB (FRA:N9X) has a EV-to-FCF of -151.31 as of Jul. 16, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on New Nordic Healthbrands AB and its competitors. According to the industry distribution chart, New Nordic Healthbrands AB ranks #999999 out of 1190 companies in the Consumer Packaged Goods industry.
Is New Nordic Healthbrands AB's EV-to-FCF too high?
New Nordic Healthbrands AB's current EV-to-FCF is -151.31. Based on the distribution chart, New Nordic Healthbrands AB ranks #999999 out of 1190 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, New Nordic Healthbrands AB has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does New Nordic Healthbrands AB's EV-to-FCF compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, New Nordic Healthbrands AB ranks #999999 out of 1190 companies for EV-to-FCF. This places New Nordic Healthbrands AB in the lower half of its industry. The industry median EV-to-FCF is 15.92. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Consumer Packaged Goods company?
The median EV-to-FCF among Consumer Packaged Goods companies is 15.92, based on 1,190 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on New Nordic Healthbrands AB and its competitors. For the Consumer Packaged Goods industry, the median EV-to-FCF is 15.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. New Nordic Healthbrands AB's current EV-to-FCF is -151.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is New Nordic Healthbrands AB stock overvalued right now?
New Nordic Healthbrands AB (FRA:N9X) has a current EV-to-FCF of -151.31. The stock's GF Value™ is €1.73, compared to a current price of €1.05 — trading 39.3% below its estimated fair value. The current EV-to-FCF is -151.31. New Nordic Healthbrands AB's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For New Nordic Healthbrands AB (FRA:N9X), the current EV-to-FCF is -151.31 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is New Nordic Healthbrands AB (FRA:N9X) Overvalued in 2026?
Based on GuruFocus' analysis, New Nordic Healthbrands AB stock appears to be undervalued.
The current stock price of €1.05 is trading 39.3% below its estimated GF Value™ of €1.73.
Key valuation signals for FRA:N9X:
EV-to-FCF: -151.31
GF Value™: €1.73 vs. price of €1.05 (39.3% below fair value)
No single metric tells the full story. See the FRA:N9X stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
New Nordic Healthbrands AB develops herbal supplements, herbal remedies, and personal care products to satisfy specific health and beauty needs. The products are sold in North America, Europe, and Asia. Some products sold are Active legs, Active Liver, Apple Cider, Chili Burn, Clear brain, Ear tone, Equazen, Frutin gastro gel, Hair Gro, Hair Volume, Kilo trim, and Melissa Dream. Maximum revenue is generated from the Nordic region.
59GF Score
Get the complete analysis for FRA:N9X
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:N9X has been successfully added to your 
